Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 and GIP Properties After Dexamethasone-Induced Insulin Resistance
NCT02235584Completed
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Jul 2009
- Primary completion
- Jun 2014
- Countries
- 1
01
Overview
Open-label trial, sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoint: The potentiating effects of GLP-1 on second phase insulin response when clamped at at bloodsugar of 7 mmol/l. Started Jul 2009; status: completed.
Beyond the preview
Go deeper on NCT02235584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02235584.